Elmwood Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-63
Closed -$7K 230
2021
Q4
$7K Buy
+63
New +$7.29K ﹤0.01% 307
2021
Q2
$8K Hold
63
﹤0.01% 267
2021
Q1
$7K Buy
+63
New +$7.38K ﹤0.01% 261
2020
Q3
$7K Hold
73
0.01% 202
2020
Q2
$7K Buy
73
+35
+92% +$3.36K 0.01% 202
2020
Q1
$3.05K Buy
+38
New +$4.04K ﹤0.01% 240
2019
Q4
Sell
-38
Closed -$4K 182
2019
Q3
$4K Hold
38
﹤0.01% 220
2019
Q2
$4K Hold
38
﹤0.01% 244
2019
Q1
$3K Hold
38
﹤0.01% 253
2018
Q4
$3K Hold
38
﹤0.01% 262
2018
Q3
$3.74K Hold
38
﹤0.01% 243
2018
Q2
$3.25K Hold
38
﹤0.01% 238
2018
Q1
$3.05K Buy
+38
New +$3.13K ﹤0.01% 240

Other funds holding MDT

Elmwood Wealth Management's MDT Position: Q1 2022 in Review

Elmwood Wealth Management sold out of Medtronic (MDT) in Q1 2022, closing a stake of 63 shares — an estimated $7K sold.

Elmwood Wealth Management first reported a position in MDT in Q1 2018 and held it in 13 quarters. The position peaked at $8K in Q2 2021. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • Elmwood Wealth Management reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
  • Elmwood Wealth Management sold 63 Medtronic shares in Q1 2022, an estimated $7K.
  • Elmwood Wealth Management first reported a position in Medtronic in Q1 2018 and held it in 13 quarters.
  • Elmwood Wealth Management's Medtronic position peaked at $8K in Q2 2021.
  • 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Elmwood Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.